TG Therapeutics
TGTX
TGTX
181 hedge funds and large institutions have $594M invested in TG Therapeutics in 2022 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 63 increasing their positions, 55 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
15% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 55
5% more funds holding
Funds holding: 172 → 181 (+9)
4.68% less ownership
Funds ownership: 73.65% → 68.96% (-4.7%)
Holders
181
Holding in Top 10
2
Calls
$42.6M
Puts
$12.2M
Top Buyers
| 1 | +$10.4M | |
| 2 | +$10.2M | |
| 3 | +$5.65M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.53M |
| 5 |
Goldman Sachs
New York
|
+$3.48M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$9.79M | |
| 3 | -$9.01M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$8.88M |
| 5 |
Renaissance Technologies
New York
|
-$5.93M |